Discovery of potential RIPK1 inhibitors by machine learning and molecular dynamics simulations

Authors:

Abstract
Six small molecules from virtual screening hits may treat neurodegenerative diseases and SARS-CoV-2 by inhibiting RIPK1.
Funding Information
  • National Natural Science Foundation of China (82173429)

This publication has 53 references indexed in Scilit: